
Probiom8 | Probiotic Treatment for Acne-Prone Skin | Probiom8
Probiotic Treatment for Acne-Prone Skin:
THE PROBIOM8 KIT
Treating blemishes will never be the same again.

A breakthrough in
PROBIOTIC TREATMENT FOR ACNE-PRONE SKIN
Probiom8 is the first skin-native probiotic treatment kit for acne-prone skin. 8 products, 8 weeks, one complete routine designed to work from within.
Scientists
Years of Research
What makes
PROBIOM8 DIFFERENT?
For years, the skincare industry treated blemishes on the surface. Eucerin went deeper. The result is a first-of-its-kind approach to probiotic skincare for acne-prone skin – one that works within the skin microbiome, not just on it.

The probiotic science behind Probiom8
TopiC.A is Eucerin's pioneering probiotic technology for acne-prone skin, backed by 20 years of research. It does what skincare has never done before – using live, beneficial bacteria from healthy human skin to restore the microbiome balance. 9 pending patents protect the science.
8 Products. 8 Weeks.
ONE TREATMENT ROUTINE FOR ACNE-PRONE SKIN.
Probiom8 is a complete set for probiotic treatment of acne-prone skin. 8 products, applied morning and evening, used across 8 weeks. Here is what comes inside:
Clinically proven results on
ACNE-PRONE SKIN

Probiotic science for acne-prone skin that works: Clinically tested on more than 3,000 patients, Probiom8 delivered a 68% reduction in pimples, alongside improvements across 8 signs. Results are visible from day 1.
* Clinical Study, Brazil 2023, lesion count, reduction of papules, median based on the 33% of subjects with the highest reduction compared to baseline, after 8 weeks
Hear more from
OUR EXPERTS
88% of dermatologists would give this probiotic acne-prone skin treatment to their own children aged 12 and over.
** 3 Interim analysis of a global multicenter real-world evidence study evaluating a dermocosmeticprobiotic routine for acne-prone skin (IGA grades 2–4), based on available data from the 8-week treatment phase (n = 1082). The presented results include expert statements from participating dermatologists (n=226)









